Global Human Recombinant Insulin Sales Market Report 2021

1 Human Recombinant Insulin Market Overview

• 1.1 Human Recombinant Insulin Product Scope
• 1.2 Human Recombinant Insulin Segment by Type
  • 1.2.1 Global Human Recombinant Insulin Sales by Type (2016 & 2021 & 2027)
  • 1.2.2 Rapid-Acting Human Insulin
  • 1.2.3 Regular (Short Acting) Insulin
  • 1.2.4 NPH (Intermediate Acting) Insulin
  • 1.2.5 Long-Acting Human Insulin
  • 1.2.6 Premixed Human Insulins Insulin
• 1.3 Human Recombinant Insulin Segment by Application
  • 1.3.1 Global Human Recombinant Insulin Sales Comparison by Application (2016 & 2021 & 2027)
  • 1.3.2 Hospital
  • 1.3.3 Retail Pharmacy
  • 1.3.4 Online Pharmacies
  • 1.3.5 Other
• 1.4 Human Recombinant Insulin Market Estimates and Forecasts (2016-2027)
  • 1.4.1 Global Human Recombinant Insulin Market Size in Value Growth Rate (2016-2027)
  • 1.4.2 Global Human Recombinant Insulin Market Size in Volume Growth Rate (2016-2027)
  • 1.4.3 Global Human Recombinant Insulin Price Trends (2016-2027)

2 Human Recombinant Insulin Estimates and Forecasts by Region

• 2.1 Global Human Recombinant Insulin Market Size by Region: 2016 VS 2021 VS 2027
• 2.2 Global Human Recombinant Insulin Retrospective Market Scenario by Region (2016-2021)
  • 2.2.1 Global Human Recombinant Insulin Sales Market Share by Region (2016-2021)
  • 2.2.2 Global Human Recombinant Insulin Revenue Market Share by Region (2016-2021)
• 2.3 Global Human Recombinant Insulin Market Estimates and Forecasts by Region (2022-2027)
  • 2.3.1 Global Human Recombinant Insulin Sales Estimates and Forecasts by Region (2022-2027)
  • 2.3.2 Global Human Recombinant Insulin Revenue Forecast by Region (2022-2027)
• 2.4 Geographic Market Analysis: Market Facts & Figures
  • 2.4.1 North America Human Recombinant Insulin Estimates and Projections (2016-2027)
  • 2.4.2 Europe Human Recombinant Insulin Estimates and Projections (2016-2027)
  • 2.4.3 China Human Recombinant Insulin Estimates and Projections (2016-2027)
  • 2.4.4 Japan Human Recombinant Insulin Estimates and Projections (2016-2027)
  • 2.4.5 Southeast Asia Human Recombinant Insulin Estimates and Projections (2016-2027)
  • 2.4.6 India Human Recombinant Insulin Estimates and Projections (2016-2027)

3 Global Human Recombinant Insulin Competition Landscape by Players

• 3.1 Global Top Human Recombinant Insulin Players by Sales (2016-2021)
• 3.2 Global Top Human Recombinant Insulin Players by Revenue (2016-2021)
• 3.3 Global Human Recombinant Insulin Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Human Recombinant Insulin as of 2020)
• 3.4 Global Human Recombinant Insulin Average Price by Company (2016-2021)
• 3.5 Manufacturers Human Recombinant Insulin Manufacturing Sites, Area Served, Product Type
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Global Human Recombinant Insulin Market Size by Type

• 4.1 Global Human Recombinant Insulin Historic Market Review by Type (2016-2021)
  • 4.1.1 Global Human Recombinant Insulin Sales Market Share by Type (2016-2021)
  • 4.1.2 Global Human Recombinant Insulin Revenue Market Share by Type (2016-2021)
  • 4.1.3 Global Human Recombinant Insulin Price by Type (2016-2021)
• 4.2 Global Human Recombinant Insulin Market Estimates and Forecasts by Type (2022-2027)
  • 4.2.1 Global Human Recombinant Insulin Sales Forecast by Type (2022-2027)
  • 4.2.2 Global Human Recombinant Insulin Revenue Forecast by Type (2022-2027)
  • 4.2.3 Global Human Recombinant Insulin Price Forecast by Type (2022-2027)

5 Global Human Recombinant Insulin Market Size by Application

• 5.1 Global Human Recombinant Insulin Historic Market Review by Application (2016-2021)
  • 5.1.1 Global Human Recombinant Insulin Sales Market Share by Application (2016-2021)
  • 5.1.2 Global Human Recombinant Insulin Revenue Market Share by Application (2016-2021)
  • 5.1.3 Global Human Recombinant Insulin Price by Application (2016-2021)
• 5.2 Global Human Recombinant Insulin Market Estimates and Forecasts by Application (2022-2027)
  • 5.2.1 Global Human Recombinant Insulin Sales Forecast by Application (2022-2027)
  • 5.2.2 Global Human Recombinant Insulin Revenue Forecast by Application (2022-2027)
  • 5.2.3 Global Human Recombinant Insulin Price Forecast by Application (2022-2027)

6 North America Human Recombinant Insulin Market Facts & Figures

• 6.1 North America Human Recombinant Insulin Sales by Company
  • 6.1.1 North America Human Recombinant Insulin Sales by Company (2016-2021)
  • 6.1.2 North America Human Recombinant Insulin Revenue by Company (2016-2021)
• 6.2 North America Human Recombinant Insulin Sales Breakdown by Type
  • 6.2.1 North America Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
  • 6.2.2 North America Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
• 6.3 North America Human Recombinant Insulin Sales Breakdown by Application
  • 6.3.1 North America Human Recombinant Insulin Sales Breakdown by Application (2016-2021)
  • 6.3.2 North America Human Recombinant Insulin Sales Breakdown by Application (2022-2027)

7 Europe Human Recombinant Insulin Market Facts & Figures

• 7.1 Europe Human Recombinant Insulin Sales by Company
  • 7.1.1 Europe Human Recombinant Insulin Sales by Company (2016-2021)
  • 7.1.2 Europe Human Recombinant Insulin Revenue by Company (2016-2021)
• 7.2 Europe Human Recombinant Insulin Sales Breakdown by Type
  • 7.2.1 Europe Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
  • 7.2.2 Europe Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
• 7.3 Europe Human Recombinant Insulin Sales Breakdown by Application
  • 7.3.1 Europe 143 Sales Breakdown by Application (2016-2021)
  • 7.3.2 Europe 143 Sales Breakdown by Application (2022-2027)

8 China Human Recombinant Insulin Market Facts & Figures

• 8.1 China Human Recombinant Insulin Sales by Company
  • 8.1.1 China Human Recombinant Insulin Sales by Company (2016-2021)
  • 8.1.2 China Human Recombinant Insulin Revenue by Company (2016-2021)
• 8.2 China Human Recombinant Insulin Sales Breakdown by Type
  • 8.2.1 China Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
  • 8.2.2 China Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
• 8.3 China Human Recombinant Insulin Sales Breakdown by Application
  • 8.3.1 China 311 Sales Breakdown by Application (2016-2021)
  • 8.3.2 China 311 Sales Breakdown by Application (2022-2027)

9 Japan Human Recombinant Insulin Market Facts & Figures

• 9.1 Japan Human Recombinant Insulin Sales by Company
  • 9.1.1 Japan Human Recombinant Insulin Sales by Company (2016-2021)
  • 9.1.2 Japan Human Recombinant Insulin Revenue by Company (2016-2021)
• 9.2 Japan Human Recombinant Insulin Sales Breakdown by Type
  • 9.2.1 Japan Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
  • 9.2.2 Japan Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
• 9.3 Japan Human Recombinant Insulin Sales Breakdown by Application
  • 9.3.1 Japan Jan. Sales Breakdown by Application (2016-2021)
  • 9.3.2 Japan Jan. Sales Breakdown by Application (2022-2027)

10 Southeast Asia Human Recombinant Insulin Market Facts & Figures

• 10.1 Southeast Asia Human Recombinant Insulin Sales by Company
  • 10.1.1 Southeast Asia Human Recombinant Insulin Sales by Company (2016-2021)
  • 10.1.2 Southeast Asia Human Recombinant Insulin Revenue by Company (2016-2021)
• 10.2 Southeast Asia Human Recombinant Insulin Sales Breakdown by Type
  • 10.2.1 Southeast Asia Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
  • 10.2.2 Southeast Asia Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
• 10.3 Southeast Asia Human Recombinant Insulin Sales Breakdown by Application
  • 10.3.1 Southeast Asia K Litre Sales Breakdown by Application (2016-2021)
  • 10.3.2 Southeast Asia K Litre Sales Breakdown by Application (2022-2027)

11 India Human Recombinant Insulin Market Facts & Figures

• 11.1 India Human Recombinant Insulin Sales by Company
  • 11.1.1 India Human Recombinant Insulin Sales by Company (2016-2021)
  • 11.1.2 India Human Recombinant Insulin Revenue by Company (2016-2021)
• 11.2 India Human Recombinant Insulin Sales Breakdown by Type
  • 11.2.1 India Human Recombinant Insulin Sales Breakdown by Type (2016-2021)
  • 11.2.2 India Human Recombinant Insulin Sales Breakdown by Type (2022-2027)
• 11.3 India Human Recombinant Insulin Sales Breakdown by Application
  • 11.3.1 India Human Recombinant Insulin Sales Breakdown by Application (2016-2021)
  • 11.3.2 India Human Recombinant Insulin Sales Breakdown by Application (2022-2027)

12 Company Profiles and Key Figures in Human Recombinant Insulin Business

• 12.1 Novo Nordisk
  • 12.1.1 Novo Nordisk Corporation Information
  • 12.1.2 Novo Nordisk Business Overview
  • 12.1.3 Novo Nordisk Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.1.4 Novo Nordisk Human Recombinant Insulin Products Offered
  • 12.1.5 Novo Nordisk Recent Development
• 12.2 Eli Lilly and Company
  • 12.2.1 Eli Lilly and Company Corporation Information
  • 12.2.2 Eli Lilly and Company Business Overview
  • 12.2.3 Eli Lilly and Company Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.2.4 Eli Lilly and Company Human Recombinant Insulin Products Offered
  • 12.2.5 Eli Lilly and Company Recent Development
• 12.3 Sanofi
  • 12.3.1 Sanofi Corporation Information
  • 12.3.2 Sanofi Business Overview
  • 12.3.3 Sanofi Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.3.4 Sanofi Human Recombinant Insulin Products Offered
  • 12.3.5 Sanofi Recent Development
• 12.4 Julphar Gulf Pharmaceutical Industries
  • 12.4.1 Julphar Gulf Pharmaceutical Industries Corporation Information
  • 12.4.2 Julphar Gulf Pharmaceutical Industries Business Overview
  • 12.4.3 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.4.4 Julphar Gulf Pharmaceutical Industries Human Recombinant Insulin Products Offered
  • 12.4.5 Julphar Gulf Pharmaceutical Industries Recent Development
• 12.5 Bioton
  • 12.5.1 Bioton Corporation Information
  • 12.5.2 Bioton Business Overview
  • 12.5.3 Bioton Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.5.4 Bioton Human Recombinant Insulin Products Offered
  • 12.5.5 Bioton Recent Development
• 12.6 Gan & Lee Pharmaceuticals
  • 12.6.1 Gan & Lee Pharmaceuticals Corporation Information
  • 12.6.2 Gan & Lee Pharmaceuticals Business Overview
  • 12.6.3 Gan & Lee Pharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.6.4 Gan & Lee Pharmaceuticals Human Recombinant Insulin Products Offered
  • 12.6.5 Gan & Lee Pharmaceuticals Recent Development
• 12.7 Zhuhai United Laboratories
  • 12.7.1 Zhuhai United Laboratories Corporation Information
  • 12.7.2 Zhuhai United Laboratories Business Overview
  • 12.7.3 Zhuhai United Laboratories Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.7.4 Zhuhai United Laboratories Human Recombinant Insulin Products Offered
  • 12.7.5 Zhuhai United Laboratories Recent Development
• 12.8 Biocon
  • 12.8.1 Biocon Corporation Information
  • 12.8.2 Biocon Business Overview
  • 12.8.3 Biocon Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.8.4 Biocon Human Recombinant Insulin Products Offered
  • 12.8.5 Biocon Recent Development
• 12.9 Wanbang Biopharmaceuticals
  • 12.9.1 Wanbang Biopharmaceuticals Corporation Information
  • 12.9.2 Wanbang Biopharmaceuticals Business Overview
  • 12.9.3 Wanbang Biopharmaceuticals Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.9.4 Wanbang Biopharmaceuticals Human Recombinant Insulin Products Offered
  • 12.9.5 Wanbang Biopharmaceuticals Recent Development
• 12.10 Dongbao Enterprise Group
  • 12.10.1 Dongbao Enterprise Group Corporation Information
  • 12.10.2 Dongbao Enterprise Group Business Overview
  • 12.10.3 Dongbao Enterprise Group Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.10.4 Dongbao Enterprise Group Human Recombinant Insulin Products Offered
  • 12.10.5 Dongbao Enterprise Group Recent Development
• 12.11 PeproTech
  • 12.11.1 PeproTech Corporation Information
  • 12.11.2 PeproTech Business Overview
  • 12.11.3 PeproTech Human Recombinant Insulin Sales, Revenue and Gross Margin (2016-2021)
  • 12.11.4 PeproTech Human Recombinant Insulin Products Offered
  • 12.11.5 PeproTech Recent Development

13 Human Recombinant Insulin Manufacturing Cost Analysis

• 13.1 Human Recombinant Insulin Key Raw Materials Analysis
  • 13.1.1 Key Raw Materials
  • 13.1.2 Key Raw Materials Price Trend
  • 13.1.3 Key Suppliers of Raw Materials
• 13.2 Proportion of Manufacturing Cost Structure
• 13.3 Manufacturing Process Analysis of Human Recombinant Insulin
• 13.4 Human Recombinant Insulin Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers

• 14.1 Marketing Channel
• 14.2 Human Recombinant Insulin Distributors List
• 14.3 Human Recombinant Insulin Customers

15 Market Dynamics

• 15.1 Human Recombinant Insulin Market Trends
• 15.2 Human Recombinant Insulin Drivers
• 15.3 Human Recombinant Insulin Market Challenges
• 15.4 Human Recombinant Insulin Market Restraints

16 Research Findings and Conclusion

17 Appendix

• 17.1 Research Methodology
  • 17.1.1 Methodology/Research Approach
  • 17.1.2 Data Source
• 17.2 Author List